News

Lingyi Biotech Advances Next-Generation Gene Therapies
SHANGHAI, CHINA / ACCESS Newswire / July 22, 2025 / Lingyi Biotech , a clinical-stage biotechnology company specializing in ...
The Manila Times13h
Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference
Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the ...
Deccan Chronicle6d
3 Hyderabad Centres In Gene Research
While GenomeIndia focuses on data and discovery, the UMMID aims to ensure that the benefits of genetic science reach every ...
Protalix Biotherapeutics Inc.: Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production ...
Interfax-Ukraine6d
Sanofi, Into-Sana medical center network announce strategic partnership
The Sanofi Biopharmaceutical Company and the Into-Sana medical center network (Kyiv, Odesa) signed a Memorandum of ...
FMIBlog19h
Enzyme Replacement Therapy Market to Nearly Double to USD21.62 Billion by 2035, Driven by Innovation and Early Diagnosis
The global Enzyme Replacement Therapy (ERT) market is poised for significant expansion, projected to reach USD 21.62 billion ...
Knowridge Science Report5d
Understanding causes of Lewy body dementia
In summary, Lewy body dementia is a complex and serious brain condition. It involves the build-up of abnormal proteins in the ...
Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its ...